# MSC-Exos Promote Healing of MHs

> **NCT03437759** · EARLY_PHASE1 · UNKNOWN · sponsor: **Tianjin Medical University** · enrollment: 44 (estimated)

## Conditions studied

- Macular Holes

## Interventions

- **BIOLOGICAL:** exosomes derived from mesenchymal stem cells (MSC-Exo)

## Key facts

- **NCT ID:** NCT03437759
- **Lead sponsor:** Tianjin Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-01
- **Primary completion:** 2018-05-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2021-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03437759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03437759, "MSC-Exos Promote Healing of MHs". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03437759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*